Induction of apoptosis by directing oncogenic Bcr-Abl into the nucleus
Zhenglan Huang(Chongqing Medical University), Wenli Feng(Children's Hospital of Chongqing Medical University)
Cited by 16
Related Papers
Inhibition of BCR/ABL Protein Expression by miR-203 Sensitizes for Imatinib Mesylate
|PLoS ONE|2013|67
The HSP90 inhibitor KW-2478 depletes the malignancy of BCR/ABL and overcomes the imatinib-resistance caused by BCR/ABL amplification
|Experimental Hematology and Oncology|2022|14
Jak2/STAT6/c-Myc pathway is vital to the pathogenicity of Philadelphia-positive acute lymphoblastic leukemia caused by P190BCR-ABL
|Cell Communication and Signaling|2023|12
Depression of oncogenecity by dephosphorylating and degrading BCR-ABL
|Oncotarget|2016|4